Long-lasting HIV drug could help people who can’t take daily PrEP pills.
- Molecular and Clinical Pharmacology, University of Liverpool
While scientists develop new drugs to treat a multitude of conditions, nanotechnology is pushing the boundaries of how we deliver them to patients - targeting delivery to cancer cells and giving a drug…
Contact Andrew for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- Joined
